Cite
HARVARD Citation
Nakagawa, M. et al. (2023). Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice. Cancer. 129 (4), pp. 590-599. [Online].